Long COVID, Chronic Pain, Musculoskeletal Pain
Conditions
Keywords
Long COVID, Chronic Pain, Musculoskeletal pain, Primary health care, Psychological factors
Brief summary
Justification: among the sequelae of Covid-19 in clinical practice we frequently find persistent neuromusculoskeletal pain. Prevalence data and the underlying mechanisms of such pain are very limited in the scientific literature. Therefore, with this research we will try to answer these questions. Main objective: to determine and characterize persistent musculoskeletal pain in Covid-19 patients. Method: two phases. First, a descriptive cross-sectional study will be carried out to estimate the prevalence of Long Covid Pain (LCP). Second phase, a case-control study will be carried out using the sample obtained in the first phase as the population. The sample will be divided into two groups: post-Covid-19 patients with LCP and post-Covid-19 patients without persistent pain (control group). The two groups will be matched according to sex, age and level of severity of the pathology. An assessment and comparison between groups will be made of the following variables: central sensitization, healthy physical condition and blood test values, which will be evaluated by means of physical examination, questionnaires and laboratory tests. Applicability of the results: this is a pioneering project at the national level, which would determine more reliably the prevalence of LCP in postcovid and could be a first step in the search for the best therapeutic strategies for these patients. This would help to improve the quality of life of these patients and to better manage the social and healthcare resources used in their treatment.
Interventions
BEHAVIORAL0
It is a case-control study, cross-sectional, so there is no intervention possible.
Sponsors
University of Valladolid
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients who have had Covid-19, with a confirmatory PCR+ test or positive antigen test and recorded in their primary care medical record. * Subjects between 18-70 years old. * Musculoskeletal pain of more than 12 weeks of evolution since the beginning of the infection. * Agree to participate in the study and sign the informed consent form.
Exclusion criteria
* History of chronic musculoskeletal pain of more than 12 weeks of evolution prior to Covid-19. * History of diagnosed major depression. * Having a diagnosis of fibromyalgia prior to Covid-19 infection. * Pregnancy. * Pain of oncologic origin. * Fracture or surgical intervention on the spine in the last year. * Bladder or bowel incontinence. * Saddle anesthesia.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quality of life (QoL) | 1 day | EQ-5D questionnaire (Qualitave of Life 5 Dimension): The EQ-5D-3L is a brief multi-attribute health status measure composed of five questions with Likert response options (descriptive system) and a visual analogue scale (EQ-VAS). The descriptive system covers five dimensions of health (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) with three levels of severity in each dimension (no problems, some problems, and extreme problems). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain Intensity | 1 day | Visual Analog Scale, VAS (0-100mm). |
| Areas of pain | 1 day | body chart, McGill questionnaire |
| Quantitative sensory tests | 1 day | temporal summation, pain detection to pressure and conditioned modulation test |
| Handgrip Strength assessment | 1 day | With a manual dynamometer. |
Countries
Spain
Contacts
Primary ContactFederico Montero Cuadrado
Outcome results
None listed